Parkinsonism‐dystonia‐2: Case‐series study from Saudi Arabia-Reference-Cited by-同舟云学术

Parkinsonism‐dystonia‐2: Case‐series study from Saudi Arabia

Published:2024-02-22 Issue:4 Volume:11 Page:1063-1066
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Almuqbil Mohammed A.¹²³,Tabassum Sadia⁴,Muthaffar Osama Y.⁵,Ghamdi Fouad⁶,Al Masseri Zainab⁷,Alsaman Abdulaziz⁸,Alkhater Reem A.⁹¹⁰¹¹^ORCID

Affiliation:

1. College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU‐HS) Riyadh Saudi Arabia

2. Division of Pediatric Neurology King Abdullah Specialist Children's Hospital (KASCH), National Guard Health Affairs (NGHA) Riyadh Saudi Arabia

3. King Abdullah International Medical Center (KAIMRC), Ministry of National Guard Riyadh Saudi Arabia

4. Department of Pediatrics King Fahad Medical City (KFMC) Riyadh Saudi Arabia

5. Department of Pediatrics, Faculty of Medicine King Abdulaziz University Jeddah Saudi Arabia

6. Department of Pediatric Neurology, Neuroscience Center King Fahad Specialist Hospital Dammam Saudi Arabia

7. Department of Pediatric, Medical Genetics Unit Qatif Central Hospital, Eastern Health Cluster, Ministry of Health Qatif Saudi Arabia

8. Department of Pediatric Neurology National Neuroscience Institute, King Fahad Medical City (KFMC) Riyadh Saudi Arabia

9. Women and Child Institute, John's Hopkins Aramco Healthcare (Jhah) Dhahran Saudi Arabia

10. John's Hopkins School of Medicine Baltimore USA

11. King Abdullah University for Science and Technology (KAUST) Thuwal Saudi Arabia

Abstract

AbstractParkinsonism‐dystonia‐2 PKDYS2 is an autosomal‐recessive disorder, caused by pathogenic biallelic variants in SLC18A2 which encodes the vesicular monoamine transporter (VMAT2) protein. PKDYS2 is a treatable neurotransmitter disease, and the rate of diagnosis of this disorder has increased significantly with the advance of genomic technologies. Our report highlights a novel pathologic variant in one case and a novel finding on MRI Brain, consisting of a normal symmetrical signal intensity in the dorsal brainstem and pons, and it substantiates the significance of genetic testing in the evaluation of children with developmental delays, which influences clinical decisions to enhance patient outcomes.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.52020

Reference8 articles.

1. A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the SLC18A2 gene

2. What is new for monoamine neurotransmitter disorders?

3. Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder

4. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals

5. Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration